Sunday, May 27, 2018
 
 
Company News: Page (1) of 1 - 09/07/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
MEDI+SIGN® Designated a ResponderSync® Partner at Rauland-Borg Corporation
 
(September 07, 2017)
MEDI+SIGN® Designated a ResponderSync® Partner at Rauland-Borg Corporation

MEDI+SIGN announces the recent designation of ResponderSync Partner by Rauland-Borg, a market leader in Nurse Call communication systems. MEDI+SIGN healthcare technology supports critical communication solutions to ensure safety of patients and plays an essential role in preventing errors and safety conflicts, fostering a safe healing environment for the patient.

MEDI+SIGN connects nurse/patient communications through Digital Patient WhiteBoard Solutions designed to improve patient satisfaction and coordination of care. MEDI+SIGN technology meets the Rauland criteria for ResponderSync level of technology by visually identifying fall risks, creating better attentiveness, supports patient safety, isolates potential infectious patients and communicates patient status clearly to patient and family.

“We are excited to be a part of the Rauland-Borg team as a certified partner," said David Linetsky, CEO/Founder of MEDI+SIGN. “We look forward to this partnership and working with Rauland-Borg to offer a solution that improves nurse staff productivity and administrative efficiency as well as patient communication."



ResponderSync improves hospital staff workflow and communications between staff and patients. With the MEDI+SIGN partnership Rauland can now offer in-room Digital Patient Whiteboards that connect the nursing and administrative staff directly to the patient for a streamlined healthcare communications solution.

Further details about MEDI+SIGN and its patient monitoring and digital whiteboard solutions are available on the company's website: http://www.medisigndisplays.com. Questions or opportunities may be addressed through the website, or by phone (301-790-0103).

About MEDI+SIGN
MEDI+SIGN provides hospital and healthcare organizations with a connected health platform that includes patient monitoring and digital whiteboard display solutions. MEDI+SIGN integrates with electronic health records and remote monitoring systems to collect and communicate updated and accurate patient health and status information to care teams and patients. MEDI+SIGN was established to leverage its proprietary visual communication technology to improve hospital and healthcare provider's performance in patient safety and satisfaction, as well as the overall quality and delivery of healthcare. For more information, please contact us at http://www.medisigndisplays.com.

About Rauland-Borg Corporation
For over 80 years, Rauland-Borg has been the industry leader in the manufacture and design of communications and life-safety equipment for institutional environments. Rauland Responder® Nurse Call combines traditional nurse call components with the latest technology and software management tools. For more information on ResponderSync and other nurse call solutions, visit their website at: https://www.rauland.com/healthcare.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14666386.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Bellevue Asset Management AG: Bellevue launches dedicated digital health fund
  • Global Chromatography Reagents Market Analysis, Growth, Trends & Forecast 2018-2023, With The Market Forecasted to Register a CAGR of More Than 7% - ResearchAndMarkets.com
  • Life Science Reagents Market to exceed US$ 67.0 Bn by 2026, Says TMR
  • Study on Poor Oral Hygiene Habits of Aging Population Underlines the Importance of Outstanding Dental Care, says Premier Care Dental Group
  • Blood Gas and Electrolyte Analyzer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2023

    Cancer
  • Genmab Announces that Janssen Will Stop Studies of Daratumumab in Combination with Anti-PD-(L)1
  • NASP Applauds Bipartisan Legislation Introduced to Reduce Drug Costs and Support Access for Seniors with Life-Threatening Specialized Conditions
  • Celgene Corporation Announces Additional $3 Billion Share Repurchase Authorization and Plans to Execute a $2 Billion Accelerated Share Repurchase Program
  • Moorestown Visiting Nurse Association joins the growing enTouch network in New Jersey
  • Achieve Life Sciences, Inc. Announces Reverse Stock Split
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines